# Development of Technologies to Facilitate the Use of and Response to Vaccines

> **NIH NIH N01** · EMERGENT PRODUCT DEVELOPMENT GAITHERSBUR · 2020 · $2,739,889

## Abstract

This contract supports the advanced development of candidate products, comprised of a vaccine component and a delivery technology, for use in post-event settings following the intentional release of a biothreat agent or naturally occurring outbreaks of infectious diseases. Such biodefense vaccine technologies are intended to simplify and expedite delivery of vaccine to large numbers of patients.

## Key facts

- **NIH application ID:** 10267018
- **Project number:** 272201000035C-P00018-9999-1
- **Recipient organization:** EMERGENT PRODUCT DEVELOPMENT GAITHERSBUR
- **Principal Investigator:** LAURENCE LEMIALE
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $2,739,889
- **Award type:** —
- **Project period:** 2015-03-20 → 2015-09-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10267018

## Citation

> US National Institutes of Health, RePORTER application 10267018, Development of Technologies to Facilitate the Use of and Response to Vaccines (272201000035C-P00018-9999-1). Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/grant/nih/10267018. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*